Clinical Trial Update: SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing SOD1 inhibition by pyrimethamine in familial amyotrophic lateral sclerosis has completed; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Familial Amyotrophic Lateral Sclerosis

Drugs mentioned

• Pyrimethamine (Pyrimethamine)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Familial Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-06-19